AddLife AB (publ) (LON:0REZ)

Market Cap	1.37B +6.4%
Revenue (ttm)	841.73M +1.5%
Net Income	45.14M +122.2%
EPS	0.37 +122.8%
Shares Out	n/a
PE Ratio	30.37
Forward PE	21.95
Dividend	0.06 (0.04%)
Ex-Dividend Date	May 9, 2025

Volume	1,397
Average Volume	7,490
Open	138.10
Previous Close	142.29
Day's Range	135.80 - 139.59
52-Week Range	134.50 - 207.60
Beta	1.76
RSI	37.23
Earnings Date	Feb 4, 2026

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis equipment. It offers products and solutions, including instruments and equipment, plastic consumables, cell biology, reagents, general ...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1906
• Employees: 2,295
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0REZ

Financial Performance

In 2025, AddLife AB's revenue was 10.44 billion, an increase of 1.52% compared to the previous year's 10.29 billion. Earnings were 560.00 million, an increase of 122.22%.

Financial numbers in SEK